The effect of ondansetron, a 5-Ht3 receptor antagonist, on fatigue severity and functional impairment in Chronic Fatigue Syndrome patients Not provided at time of registration

• Country Netherlands
• organs None
• Specialty None

A 52 week double blind randomised controlled trial comparing the effect of rosiglitazone versus placebo on the prevention of progression of atherosclerosis in high risk patients without diabetes Not provided at time of registration

• Country None
• organs None
• Specialty None